One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology

Giovanni Paolo Talarico; Francesco Burzotta; Carlo Trani; Antonella Tommasino; Giampaolo Niccoli; Italo Porto; Antonio Maria Leone; Rocco Mongiardo; Giovanni Schiavoni; Filippo Crea

doi:10.1002/ccd.24498

One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology

Giovanni Paolo Talarico
, Francesco Burzotta
, Carlo Trani
, Antonella Tommasino
, Giampaolo Niccoli
, Italo Porto
, Antonio Maria Leone
, Rocco Mongiardo
, Giovanni Schiavoni
, Filippo Crea

Risultato della ricerca: Contributo in rivista › Articolo

7 Citazioni (Scopus)

Abstract

Polymer-coating represents a key component of drug-eluting stent (DES) technology and its possible impact on vessel-wall healing is a matter of debate. The clinical impact of different polymer-coating may be assessed by comparing the outcome of patients treated by DES having the same stent platform and drug, and differing in the polymer. Thus, we compared the clinical outcome of patients treated by Endeavor Zotarolimus-eluting stent (E-ZES) and Resolute Zotarolimus-eluting stent (R-ZES) as they differ in the polymer-coating only.

Lingua originale	Inglese
pagine (da-a)	268-273
Numero di pagine	6
Rivista	Catheterization and Cardiovascular Interventions
Volume	81
DOI	https://doi.org/10.1002/ccd.24498
Stato di pubblicazione	Pubblicato - 2013

Keywords

percutaneus coronary interventions
zotarolimus eluting-stents

Accesso al documento

10.1002/ccd.24498

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Talarico, G. P., Burzotta, F., Trani, C., Tommasino, A., Niccoli, G., Porto, I., Leone, A. M., Mongiardo, R., Schiavoni, G., & Crea, F. (2013). One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology. Catheterization and Cardiovascular Interventions, 81, 268-273. https://doi.org/10.1002/ccd.24498

@article{f21219f13a144c8c91b23e0412720949,

title = "One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology",

abstract = "Polymer-coating represents a key component of drug-eluting stent (DES) technology and its possible impact on vessel-wall healing is a matter of debate. The clinical impact of different polymer-coating may be assessed by comparing the outcome of patients treated by DES having the same stent platform and drug, and differing in the polymer. Thus, we compared the clinical outcome of patients treated by Endeavor Zotarolimus-eluting stent (E-ZES) and Resolute Zotarolimus-eluting stent (R-ZES) as they differ in the polymer-coating only.",

keywords = "percutaneus coronary interventions, zotarolimus eluting-stents, percutaneus coronary interventions, zotarolimus eluting-stents",

author = "Talarico, \{Giovanni Paolo\} and Francesco Burzotta and Carlo Trani and Antonella Tommasino and Giampaolo Niccoli and Italo Porto and Leone, \{Antonio Maria\} and Rocco Mongiardo and Giovanni Schiavoni and Filippo Crea",

year = "2013",

doi = "10.1002/ccd.24498",

language = "English",

volume = "81",

pages = "268--273",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-726X",

publisher = "John Wiley and Sons Inc.",

}

Talarico, GP, Burzotta, F , Trani, C, Tommasino, A, Niccoli, G, Porto, I, Leone, AM, Mongiardo, R, Schiavoni, G & Crea, F 2013, 'One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology', Catheterization and Cardiovascular Interventions, vol. 81, pagg. 268-273. https://doi.org/10.1002/ccd.24498

One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology. / Talarico, Giovanni Paolo; Burzotta, Francesco ; Trani, Carlo et al.
In: Catheterization and Cardiovascular Interventions, Vol. 81, 2013, pag. 268-273.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology

AU - Talarico, Giovanni Paolo

AU - Burzotta, Francesco

AU - Trani, Carlo

AU - Tommasino, Antonella

AU - Niccoli, Giampaolo

AU - Porto, Italo

AU - Leone, Antonio Maria

AU - Mongiardo, Rocco

AU - Schiavoni, Giovanni

AU - Crea, Filippo

PY - 2013

Y1 - 2013

N2 - Polymer-coating represents a key component of drug-eluting stent (DES) technology and its possible impact on vessel-wall healing is a matter of debate. The clinical impact of different polymer-coating may be assessed by comparing the outcome of patients treated by DES having the same stent platform and drug, and differing in the polymer. Thus, we compared the clinical outcome of patients treated by Endeavor Zotarolimus-eluting stent (E-ZES) and Resolute Zotarolimus-eluting stent (R-ZES) as they differ in the polymer-coating only.

AB - Polymer-coating represents a key component of drug-eluting stent (DES) technology and its possible impact on vessel-wall healing is a matter of debate. The clinical impact of different polymer-coating may be assessed by comparing the outcome of patients treated by DES having the same stent platform and drug, and differing in the polymer. Thus, we compared the clinical outcome of patients treated by Endeavor Zotarolimus-eluting stent (E-ZES) and Resolute Zotarolimus-eluting stent (R-ZES) as they differ in the polymer-coating only.

KW - percutaneus coronary interventions

KW - zotarolimus eluting-stents

KW - percutaneus coronary interventions

KW - zotarolimus eluting-stents

UR - http://hdl.handle.net/10807/41467

U2 - 10.1002/ccd.24498

DO - 10.1002/ccd.24498

M3 - Article

SN - 1522-726X

VL - 81

SP - 268

EP - 273

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

ER -

One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo